With BI 3720931, Boehringer and its partners are hoping to fulfil that need and provide an option for the estimated 10% to 15% of patients for whom there are no suitable CFTR modulators available.
Methods We conducted a retrospective cohort study examining patients who commenced the CFTR modulator ivacaftor. Over a period of 5 years we monitored the isolation ofAspergillus in sputum samples and ...
Tl says it has come up with “the first fully functional isolated modulators”, helping designers achieve more precise motor control in compact robot designs. The AMC0106M05, AMC0136 and AMC0106M25 ...
- VX-264 Phase 1/2 enrollment and dosing complete in Parts A and B: VX-264 was generally safe and well tolerated; efficacy data are not supportive of further clinical advancement - - Zimislecel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback